EP 2139334 A1 20100106 - 2-CYANOPHENYL FUSED HETEROCYCLIC COMPOUNDS, AND COMPOSITIONS AND USES THEREOF
Title (en)
2-CYANOPHENYL FUSED HETEROCYCLIC COMPOUNDS, AND COMPOSITIONS AND USES THEREOF
Title (de)
KONDENSIERTE HETEROZYKLISCHE 2-CYANOPHENYL-VERBINDUNGEN UND ZUSAMMENSETZUNGEN SOWIE IHRE ANWENDUNG
Title (fr)
COMPOSÉS HÉTÉROCYCLIQUES FUSIONNÉS DE 2-CYANOPHÉNYLE, COMPOSITIONS ET UTILISATIONS DE CEUX-CI
Publication
Application
Priority
- US 2008004208 W 20080331
- US 92510907 P 20070417
- US 1051208 P 20080108
Abstract (en)
[origin: WO2008130481A1] Fused heterocyclic compounds are provided according to formula (1): where R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, and m are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.
IPC 8 full level
A61K 31/519 (2006.01); A61P 25/00 (2006.01); C07D 417/04 (2006.01); C07D 519/00 (2006.01)
CPC (source: EP US)
A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/02 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 13/10 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 17/04 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 471/04 (2013.01 - EP US); C07D 519/00 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2008130481 A1 20081030; CA 2682692 A1 20081030; CN 101677569 A 20100324; CN 101677569 B 20140122; CY 1114382 T1 20160831; DK 2139334 T3 20130923; EP 2139334 A1 20100106; EP 2139334 A4 20110622; EP 2139334 B1 20130703; ES 2427999 T3 20131105; HR P20130867 T1 20131025; JP 2010524930 A 20100722; JP 5498374 B2 20140521; PL 2139334 T3 20131129; PT 2139334 E 20131002; US 2008275037 A1 20081106; US 2012149700 A1 20120614; US 8076345 B2 20111213
DOCDB simple family (application)
US 2008004208 W 20080331; CA 2682692 A 20080331; CN 200880016706 A 20080331; CY 131100796 T 20130916; DK 08742430 T 20080331; EP 08742430 A 20080331; ES 08742430 T 20080331; HR P20130867 T 20130916; JP 2010504040 A 20080331; PL 08742430 T 20080331; PT 08742430 T 20080331; US 201113323748 A 20111212; US 8025308 A 20080331